The global market for Piroxicam Oral Tablets was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Piroxicam is a nonsteroidal anti-inflammatory drug, a widely used subclass of active pharmaceutical ingredients (APIs) in medicines. These drugs generally have analgesic (pain-relieving), anti-inflammatory and antipyretic (fever-reducing) properties. NSAIDs work by inhibiting the production of certain enzymes called cyclooxygenases (COX), which play a vital role in the synthesis of prostaglandins (substances that cause pain, inflammation and fever).

North American market for Piroxicam Oral Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Piroxicam Oral Tablets is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Piroxicam Oral Tablets include SK Chemical, Chr. Olesen Group, Adva Care Pharma, Wellona Pharma, Pfizer, Nantong Jinghua Pharmaceutical, Yunpeng Pharmaceutical Group, Wanrong Pharmaceutical (Langzhi Group), Shandong Fangming Pharmaceutical Group, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Piroxicam Oral Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Piroxicam Oral Tablets.

The Piroxicam Oral Tablets market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Piroxicam Oral Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Piroxicam Oral Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Piroxicam Oral Tablets Market Report

Report Metric	Details
Report Name	Piroxicam Oral Tablets Market
Segment by Type	Regular Release Tablets Modified Release Tablets
Segment by Application	Hospital Clinic Pharmacy
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	SK Chemical, Chr. Olesen Group, Adva Care Pharma, Wellona Pharma, Pfizer, Nantong Jinghua Pharmaceutical, Yunpeng Pharmaceutical Group, Wanrong Pharmaceutical (Langzhi Group), Shandong Fangming Pharmaceutical Group
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Piroxicam Oral Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Piroxicam Oral Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Piroxicam Oral Tablets Market report?

Ans: The main players in the Piroxicam Oral Tablets Market are SK Chemical, Chr. Olesen Group, Adva Care Pharma, Wellona Pharma, Pfizer, Nantong Jinghua Pharmaceutical, Yunpeng Pharmaceutical Group, Wanrong Pharmaceutical (Langzhi Group), Shandong Fangming Pharmaceutical Group

What are the Application segmentation covered in the Piroxicam Oral Tablets Market report?

Ans: The Applications covered in the Piroxicam Oral Tablets Market report are Hospital, Clinic, Pharmacy

What are the Type segmentation covered in the Piroxicam Oral Tablets Market report?

Ans: The Types covered in the Piroxicam Oral Tablets Market report are Regular Release Tablets, Modified Release Tablets

1 Piroxicam Oral Tablets Market Overview

1.1 Product Definition

1.2 Piroxicam Oral Tablets by Type

1.2.1 Global Piroxicam Oral Tablets Market Value Comparison by Type (2024 VS 2031)

1.2.2 Regular Release Tablets

1.2.3 Modified Release Tablets

1.3 Piroxicam Oral Tablets by Application

1.3.1 Global Piroxicam Oral Tablets Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Pharmacy

1.4 Global Piroxicam Oral Tablets Market Size Estimates and Forecasts

1.4.1 Global Piroxicam Oral Tablets Revenue 2020-2031

1.4.2 Global Piroxicam Oral Tablets Sales 2020-2031

1.4.3 Global Piroxicam Oral Tablets Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Piroxicam Oral Tablets Market Competition by Manufacturers

2.1 Global Piroxicam Oral Tablets Sales Market Share by Manufacturers (2020-2025)

2.2 Global Piroxicam Oral Tablets Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Piroxicam Oral Tablets Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Piroxicam Oral Tablets, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Piroxicam Oral Tablets, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Piroxicam Oral Tablets, Product Type & Application

2.7 Global Key Manufacturers of Piroxicam Oral Tablets, Date of Enter into This Industry

2.8 Global Piroxicam Oral Tablets Market Competitive Situation and Trends

2.8.1 Global Piroxicam Oral Tablets Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Piroxicam Oral Tablets Players Market Share by Revenue

2.8.3 Global Piroxicam Oral Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Piroxicam Oral Tablets Market Scenario by Region

3.1 Global Piroxicam Oral Tablets Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Piroxicam Oral Tablets Sales by Region: 2020-2031

3.2.1 Global Piroxicam Oral Tablets Sales by Region: 2020-2025

3.2.2 Global Piroxicam Oral Tablets Sales by Region: 2026-2031

3.3 Global Piroxicam Oral Tablets Revenue by Region: 2020-2031

3.3.1 Global Piroxicam Oral Tablets Revenue by Region: 2020-2025

3.3.2 Global Piroxicam Oral Tablets Revenue by Region: 2026-2031

3.4 North America Piroxicam Oral Tablets Market Facts & Figures by Country

3.4.1 North America Piroxicam Oral Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Piroxicam Oral Tablets Sales by Country (2020-2031)

3.4.3 North America Piroxicam Oral Tablets Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Piroxicam Oral Tablets Market Facts & Figures by Country

3.5.1 Europe Piroxicam Oral Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Piroxicam Oral Tablets Sales by Country (2020-2031)

3.5.3 Europe Piroxicam Oral Tablets Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Piroxicam Oral Tablets Market Facts & Figures by Region

3.6.1 Asia Pacific Piroxicam Oral Tablets Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Piroxicam Oral Tablets Sales by Region (2020-2031)

3.6.3 Asia Pacific Piroxicam Oral Tablets Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Piroxicam Oral Tablets Market Facts & Figures by Country

3.7.1 Latin America Piroxicam Oral Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Piroxicam Oral Tablets Sales by Country (2020-2031)

3.7.3 Latin America Piroxicam Oral Tablets Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Piroxicam Oral Tablets Market Facts & Figures by Country

3.8.1 Middle East and Africa Piroxicam Oral Tablets Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Piroxicam Oral Tablets Sales by Country (2020-2031)

3.8.3 Middle East and Africa Piroxicam Oral Tablets Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Piroxicam Oral Tablets Sales by Type (2020-2031)

4.1.1 Global Piroxicam Oral Tablets Sales by Type (2020-2025)

4.1.2 Global Piroxicam Oral Tablets Sales by Type (2026-2031)

4.1.3 Global Piroxicam Oral Tablets Sales Market Share by Type (2020-2031)

4.2 Global Piroxicam Oral Tablets Revenue by Type (2020-2031)

4.2.1 Global Piroxicam Oral Tablets Revenue by Type (2020-2025)

4.2.2 Global Piroxicam Oral Tablets Revenue by Type (2026-2031)

4.2.3 Global Piroxicam Oral Tablets Revenue Market Share by Type (2020-2031)

4.3 Global Piroxicam Oral Tablets Price by Type (2020-2031)

5 Segment by Application

5.1 Global Piroxicam Oral Tablets Sales by Application (2020-2031)

5.1.1 Global Piroxicam Oral Tablets Sales by Application (2020-2025)

5.1.2 Global Piroxicam Oral Tablets Sales by Application (2026-2031)

5.1.3 Global Piroxicam Oral Tablets Sales Market Share by Application (2020-2031)

5.2 Global Piroxicam Oral Tablets Revenue by Application (2020-2031)

5.2.1 Global Piroxicam Oral Tablets Revenue by Application (2020-2025)

5.2.2 Global Piroxicam Oral Tablets Revenue by Application (2026-2031)

5.2.3 Global Piroxicam Oral Tablets Revenue Market Share by Application (2020-2031)

5.3 Global Piroxicam Oral Tablets Price by Application (2020-2031)

6 Key Companies Profiled

6.1 SK Chemical

6.1.1 SK Chemical Company Information

6.1.2 SK Chemical Description and Business Overview

6.1.3 SK Chemical Piroxicam Oral Tablets Sales, Revenue and Gross Margin (2020-2025)

6.1.4 SK Chemical Piroxicam Oral Tablets Product Portfolio

6.1.5 SK Chemical Recent Developments/Updates

6.2 Chr. Olesen Group

6.2.1 Chr. Olesen Group Company Information

6.2.2 Chr. Olesen Group Description and Business Overview

6.2.3 Chr. Olesen Group Piroxicam Oral Tablets Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Chr. Olesen Group Piroxicam Oral Tablets Product Portfolio

6.2.5 Chr. Olesen Group Recent Developments/Updates

6.3 Adva Care Pharma

6.3.1 Adva Care Pharma Company Information

6.3.2 Adva Care Pharma Description and Business Overview

6.3.3 Adva Care Pharma Piroxicam Oral Tablets Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Adva Care Pharma Piroxicam Oral Tablets Product Portfolio

6.3.5 Adva Care Pharma Recent Developments/Updates

6.4 Wellona Pharma

6.4.1 Wellona Pharma Company Information

6.4.2 Wellona Pharma Description and Business Overview

6.4.3 Wellona Pharma Piroxicam Oral Tablets Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Wellona Pharma Piroxicam Oral Tablets Product Portfolio

6.4.5 Wellona Pharma Recent Developments/Updates

6.5 Pfizer

6.5.1 Pfizer Company Information

6.5.2 Pfizer Description and Business Overview

6.5.3 Pfizer Piroxicam Oral Tablets Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Pfizer Piroxicam Oral Tablets Product Portfolio

6.5.5 Pfizer Recent Developments/Updates

6.6 Nantong Jinghua Pharmaceutical

6.6.1 Nantong Jinghua Pharmaceutical Company Information

6.6.2 Nantong Jinghua Pharmaceutical Description and Business Overview

6.6.3 Nantong Jinghua Pharmaceutical Piroxicam Oral Tablets Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Nantong Jinghua Pharmaceutical Piroxicam Oral Tablets Product Portfolio

6.6.5 Nantong Jinghua Pharmaceutical Recent Developments/Updates

6.7 Yunpeng Pharmaceutical Group

6.7.1 Yunpeng Pharmaceutical Group Company Information

6.7.2 Yunpeng Pharmaceutical Group Description and Business Overview

6.7.3 Yunpeng Pharmaceutical Group Piroxicam Oral Tablets Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Yunpeng Pharmaceutical Group Piroxicam Oral Tablets Product Portfolio

6.7.5 Yunpeng Pharmaceutical Group Recent Developments/Updates

6.8 Wanrong Pharmaceutical (Langzhi Group)

6.8.1 Wanrong Pharmaceutical (Langzhi Group) Company Information

6.8.2 Wanrong Pharmaceutical (Langzhi Group) Description and Business Overview

6.8.3 Wanrong Pharmaceutical (Langzhi Group) Piroxicam Oral Tablets Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Wanrong Pharmaceutical (Langzhi Group) Piroxicam Oral Tablets Product Portfolio

6.8.5 Wanrong Pharmaceutical (Langzhi Group) Recent Developments/Updates

6.9 Shandong Fangming Pharmaceutical Group

6.9.1 Shandong Fangming Pharmaceutical Group Company Information

6.9.2 Shandong Fangming Pharmaceutical Group Description and Business Overview

6.9.3 Shandong Fangming Pharmaceutical Group Piroxicam Oral Tablets Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Shandong Fangming Pharmaceutical Group Piroxicam Oral Tablets Product Portfolio

6.9.5 Shandong Fangming Pharmaceutical Group Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Piroxicam Oral Tablets Industry Chain Analysis

7.2 Piroxicam Oral Tablets Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Piroxicam Oral Tablets Production Mode & Process Analysis

7.4 Piroxicam Oral Tablets Sales and Marketing

7.4.1 Piroxicam Oral Tablets Sales Channels

7.4.2 Piroxicam Oral Tablets Distributors

7.5 Piroxicam Oral Tablets Customer Analysis

8 Piroxicam Oral Tablets Market Dynamics

8.1 Piroxicam Oral Tablets Industry Trends

8.2 Piroxicam Oral Tablets Market Drivers

8.3 Piroxicam Oral Tablets Market Challenges

8.4 Piroxicam Oral Tablets Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

SK Chemical

Wellona Pharma

Pfizer Inc

Nantong Jinghua Pharmaceutical

Yunpeng Pharmaceutical Group

Shandong Fangming Pharmaceutical Group

Chr. Olesen Group

Adva Care Pharma

Wanrong Pharmaceutical (Langzhi Group)

List of Tables

Table 1. Global Piroxicam Oral Tablets Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Piroxicam Oral Tablets Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Piroxicam Oral Tablets Market Competitive Situation by Manufacturers in 2024

Table 4. Global Piroxicam Oral Tablets Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Piroxicam Oral Tablets Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Piroxicam Oral Tablets Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Piroxicam Oral Tablets Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Piroxicam Oral Tablets Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Piroxicam Oral Tablets, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Piroxicam Oral Tablets, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Piroxicam Oral Tablets, Product Type & Application

Table 12. Global Key Manufacturers of Piroxicam Oral Tablets, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Piroxicam Oral Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Piroxicam Oral Tablets as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Piroxicam Oral Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Piroxicam Oral Tablets Sales by Region (2020-2025) & (K Units)

Table 18. Global Piroxicam Oral Tablets Sales Market Share by Region (2020-2025)

Table 19. Global Piroxicam Oral Tablets Sales by Region (2026-2031) & (K Units)

Table 20. Global Piroxicam Oral Tablets Sales Market Share by Region (2026-2031)

Table 21. Global Piroxicam Oral Tablets Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Piroxicam Oral Tablets Revenue Market Share by Region (2020-2025)

Table 23. Global Piroxicam Oral Tablets Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Piroxicam Oral Tablets Revenue Market Share by Region (2026-2031)

Table 25. North America Piroxicam Oral Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Piroxicam Oral Tablets Sales by Country (2020-2025) & (K Units)

Table 27. North America Piroxicam Oral Tablets Sales by Country (2026-2031) & (K Units)

Table 28. North America Piroxicam Oral Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Piroxicam Oral Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Piroxicam Oral Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Piroxicam Oral Tablets Sales by Country (2020-2025) & (K Units)

Table 32. Europe Piroxicam Oral Tablets Sales by Country (2026-2031) & (K Units)

Table 33. Europe Piroxicam Oral Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Piroxicam Oral Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Piroxicam Oral Tablets Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Piroxicam Oral Tablets Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Piroxicam Oral Tablets Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Piroxicam Oral Tablets Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Piroxicam Oral Tablets Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Piroxicam Oral Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Piroxicam Oral Tablets Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Piroxicam Oral Tablets Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Piroxicam Oral Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Piroxicam Oral Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Piroxicam Oral Tablets Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Piroxicam Oral Tablets Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Piroxicam Oral Tablets Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Piroxicam Oral Tablets Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Piroxicam Oral Tablets Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Piroxicam Oral Tablets Sales (K Units) by Type (2020-2025)

Table 51. Global Piroxicam Oral Tablets Sales (K Units) by Type (2026-2031)

Table 52. Global Piroxicam Oral Tablets Sales Market Share by Type (2020-2025)

Table 53. Global Piroxicam Oral Tablets Sales Market Share by Type (2026-2031)

Table 54. Global Piroxicam Oral Tablets Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Piroxicam Oral Tablets Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Piroxicam Oral Tablets Revenue Market Share by Type (2020-2025)

Table 57. Global Piroxicam Oral Tablets Revenue Market Share by Type (2026-2031)

Table 58. Global Piroxicam Oral Tablets Price (US$/Unit) by Type (2020-2025)

Table 59. Global Piroxicam Oral Tablets Price (US$/Unit) by Type (2026-2031)

Table 60. Global Piroxicam Oral Tablets Sales (K Units) by Application (2020-2025)

Table 61. Global Piroxicam Oral Tablets Sales (K Units) by Application (2026-2031)

Table 62. Global Piroxicam Oral Tablets Sales Market Share by Application (2020-2025)

Table 63. Global Piroxicam Oral Tablets Sales Market Share by Application (2026-2031)

Table 64. Global Piroxicam Oral Tablets Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Piroxicam Oral Tablets Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Piroxicam Oral Tablets Revenue Market Share by Application (2020-2025)

Table 67. Global Piroxicam Oral Tablets Revenue Market Share by Application (2026-2031)

Table 68. Global Piroxicam Oral Tablets Price (US$/Unit) by Application (2020-2025)

Table 69. Global Piroxicam Oral Tablets Price (US$/Unit) by Application (2026-2031)

Table 70. SK Chemical Company Information

Table 71. SK Chemical Description and Business Overview

Table 72. SK Chemical Piroxicam Oral Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. SK Chemical Piroxicam Oral Tablets Product

Table 74. SK Chemical Recent Developments/Updates

Table 75. Chr. Olesen Group Company Information

Table 76. Chr. Olesen Group Description and Business Overview

Table 77. Chr. Olesen Group Piroxicam Oral Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Chr. Olesen Group Piroxicam Oral Tablets Product

Table 79. Chr. Olesen Group Recent Developments/Updates

Table 80. Adva Care Pharma Company Information

Table 81. Adva Care Pharma Description and Business Overview

Table 82. Adva Care Pharma Piroxicam Oral Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Adva Care Pharma Piroxicam Oral Tablets Product

Table 84. Adva Care Pharma Recent Developments/Updates

Table 85. Wellona Pharma Company Information

Table 86. Wellona Pharma Description and Business Overview

Table 87. Wellona Pharma Piroxicam Oral Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Wellona Pharma Piroxicam Oral Tablets Product

Table 89. Wellona Pharma Recent Developments/Updates

Table 90. Pfizer Company Information

Table 91. Pfizer Description and Business Overview

Table 92. Pfizer Piroxicam Oral Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Pfizer Piroxicam Oral Tablets Product

Table 94. Pfizer Recent Developments/Updates

Table 95. Nantong Jinghua Pharmaceutical Company Information

Table 96. Nantong Jinghua Pharmaceutical Description and Business Overview

Table 97. Nantong Jinghua Pharmaceutical Piroxicam Oral Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Nantong Jinghua Pharmaceutical Piroxicam Oral Tablets Product

Table 99. Nantong Jinghua Pharmaceutical Recent Developments/Updates

Table 100. Yunpeng Pharmaceutical Group Company Information

Table 101. Yunpeng Pharmaceutical Group Description and Business Overview

Table 102. Yunpeng Pharmaceutical Group Piroxicam Oral Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Yunpeng Pharmaceutical Group Piroxicam Oral Tablets Product

Table 104. Yunpeng Pharmaceutical Group Recent Developments/Updates

Table 105. Wanrong Pharmaceutical (Langzhi Group) Company Information

Table 106. Wanrong Pharmaceutical (Langzhi Group) Description and Business Overview

Table 107. Wanrong Pharmaceutical (Langzhi Group) Piroxicam Oral Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Wanrong Pharmaceutical (Langzhi Group) Piroxicam Oral Tablets Product

Table 109. Wanrong Pharmaceutical (Langzhi Group) Recent Developments/Updates

Table 110. Shandong Fangming Pharmaceutical Group Company Information

Table 111. Shandong Fangming Pharmaceutical Group Description and Business Overview

Table 112. Shandong Fangming Pharmaceutical Group Piroxicam Oral Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Shandong Fangming Pharmaceutical Group Piroxicam Oral Tablets Product

Table 114. Shandong Fangming Pharmaceutical Group Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Piroxicam Oral Tablets Distributors List

Table 118. Piroxicam Oral Tablets Customers List

Table 119. Piroxicam Oral Tablets Market Trends

Table 120. Piroxicam Oral Tablets Market Drivers

Table 121. Piroxicam Oral Tablets Market Challenges

Table 122. Piroxicam Oral Tablets Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Piroxicam Oral Tablets

Figure 2. Global Piroxicam Oral Tablets Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Piroxicam Oral Tablets Market Share by Type: 2024 & 2031

Figure 4. Regular Release Tablets Product Picture

Figure 5. Modified Release Tablets Product Picture

Figure 6. Global Piroxicam Oral Tablets Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Piroxicam Oral Tablets Market Share by Application: 2024 & 2031

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Pharmacy

Figure 11. Global Piroxicam Oral Tablets Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Piroxicam Oral Tablets Market Size (2020-2031) & (US$ Million)

Figure 13. Global Piroxicam Oral Tablets Sales (2020-2031) & (K Units)

Figure 14. Global Piroxicam Oral Tablets Average Price (US$/Unit) & (2020-2031)

Figure 15. Piroxicam Oral Tablets Report Years Considered

Figure 16. Piroxicam Oral Tablets Sales Share by Manufacturers in 2024

Figure 17. Global Piroxicam Oral Tablets Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Piroxicam Oral Tablets Players: Market Share by Revenue in Piroxicam Oral Tablets in 2024

Figure 19. Piroxicam Oral Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Piroxicam Oral Tablets Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Piroxicam Oral Tablets Sales Market Share by Country (2020-2031)

Figure 22. North America Piroxicam Oral Tablets Revenue Market Share by Country (2020-2031)

Figure 23. United States Piroxicam Oral Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Piroxicam Oral Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Piroxicam Oral Tablets Sales Market Share by Country (2020-2031)

Figure 26. Europe Piroxicam Oral Tablets Revenue Market Share by Country (2020-2031)

Figure 27. Germany Piroxicam Oral Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Piroxicam Oral Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Piroxicam Oral Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Piroxicam Oral Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Piroxicam Oral Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Piroxicam Oral Tablets Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Piroxicam Oral Tablets Revenue Market Share by Region (2020-2031)

Figure 34. China Piroxicam Oral Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Piroxicam Oral Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Piroxicam Oral Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Piroxicam Oral Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Piroxicam Oral Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Piroxicam Oral Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Piroxicam Oral Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Latin America Piroxicam Oral Tablets Sales Market Share by Country (2020-2031)

Figure 42. Latin America Piroxicam Oral Tablets Revenue Market Share by Country (2020-2031)

Figure 43. Mexico Piroxicam Oral Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Brazil Piroxicam Oral Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Argentina Piroxicam Oral Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Colombia Piroxicam Oral Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Piroxicam Oral Tablets Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Piroxicam Oral Tablets Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Piroxicam Oral Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Piroxicam Oral Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Piroxicam Oral Tablets Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Piroxicam Oral Tablets by Type (2020-2031)

Figure 53. Global Revenue Market Share of Piroxicam Oral Tablets by Type (2020-2031)

Figure 54. Global Piroxicam Oral Tablets Price (US$/Unit) by Type (2020-2031)

Figure 55. Global Sales Market Share of Piroxicam Oral Tablets by Application (2020-2031)

Figure 56. Global Revenue Market Share of Piroxicam Oral Tablets by Application (2020-2031)

Figure 57. Global Piroxicam Oral Tablets Price (US$/Unit) by Application (2020-2031)

Figure 58. Piroxicam Oral Tablets Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions